Literature DB >> 2395751

Intravenous verapamil for tachyarrhythmia in Duchenne's muscular dystrophy.

Y Ilan, M Hillman, R Oren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2395751     DOI： 10.1007/bf02238855

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  6 in total

Review 1.  Drug therapy: Disorders of neuromuscular transmission caused by drugs.

Authors:  Z Argov; F L Mastaglia
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

2.  Effects of verapamil on excitation-contraction coupling in frog sartorius muscle.

Authors:  A Y Bondi
Journal:  J Pharmacol Exp Ther       Date:  1978-04       Impact factor: 4.030

Review 3.  Cardiac involvement in heredofamilial neuromyopathic diseases.

Authors:  J K Perloff
Journal:  Cardiovasc Clin       Date:  1972

4.  Verapamil in Duchenne muscular dystrophy.

Authors:  A E Emery; R Skinner; L C Howden; M B Matthews
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

5.  Acute respiratory failure following intravenous verapamil in Duchenne's muscular dystrophy.

Authors:  F Zalman; J K Perloff; N N Durant; D S Campion
Journal:  Am Heart J       Date:  1983-03       Impact factor: 4.749

6.  Alteration of calcium transport in Duchenne erythrocytes.

Authors:  J E Mollman; J C Cardenas; D E Pleasure
Journal:  Neurology       Date:  1980-11       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.